OUR
Press Releases

Regulatory Position On Complementary Medicines Containing Zinc Picolinate And Selenium
Gaborone: 20/01/2026 The Botswana Medicines Regulatory Authority (BoMRA) has noted the cautionary media statement issued by the South African Health Products Regulatory Authority (SAHPRA) regarding

Botswana Health Emergency Preparedness, Response and Resilience Project Using the Multi-Phase Programmatic Approach (MPA)(P 510190)
The Republic of Botswana (the Recipient) is planning to implement the proposed Botswana Health Emergency Preparedness, Response and Resilience Project using the Multi-Phase Programmatic Approach

Botswana Health Emergency Preparedness, Response and Resilience Project Using the Multi-Phase Programmatic Approach (MPA)(P 510190)
Stakeholder Engagement Plan (SEP) This project is proposed under the Health Emergency Preparedness, Response and Resilience (HEPRR) Program using the Multiphase Programmatic Approach (MPA) and

CALL FOR PARTICIPATION IN BRIMS TESTING FOR MEDICAL DEVICES MODULE
Botswana Medicines Regulatory Authority (BoMRA) invites Medical Devices Stakeholders (Manufacturers, Distributors, Authorized Representatives etc.) to participate in the final testing and validation phase of the

STAKEHOLDER ENGAGEMENT-MEDICAL DEVICES INCLUDING IN VITRO DIAGNOSTICS
The Medical Devices Unit in the Department of Product Evaluation & Registration at BoMRAwill conduct stakeholder sessions to discuss the Medical Devices including In Vitro

Executive Leadership Announcements
The Board and Management at Botswana Medicines Regulatory Authority (BoMRA) wishes to announce the appointment of Shirley Amogelang Pine, as the Director, Human Resource & Organizational Development and Bathusi Kgosietsile as the Director, Product Evaluation and Registration.






